Effects of TPA dose variation and mezerein on skin tumorigenesis by initiation promotion protocol in S/RV Cri mice.
Bhisey
R A
RA
Veturkar
P L
PL
Jeyapaul
J
J
Borges
A
A
D000818:Animals; D002273:Carcinogens; D004195:Disease Models, Animal; D004224:Diterpenes; D004305:Dose-Response Relationship, Drug; D005260:Female; D051379:Mice; D010212:Papilloma / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000139:chemically induced*; D013729:Terpenes / Q000633:toxicity*; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity*
D002273:Carcinogens; D004224:Diterpenes; D013729:Terpenes; C011309:mezerein; D013755:Tetradecanoylphorbol Acetate